Full Text View
Tabular View
No Study Results Posted
Related Studies
Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study
This study has been completed.
Study NCT00001255   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Severe Combined Immunodeficiency
Additional conditions recognized in this trial
Immunologic Deficiency Syndromes
More general conditions related to this trial
DNA Repair-Deficiency Disorders
Immune System Diseases
Infant, Newborn, Diseases
Metabolic Diseases
Interventions listed in this trial
ADA PBSC
ADA Umbilical Cord Blood Cells
Transduced Lymphocytes
Additional drug interventions recognized in this trial
Adenosine
More general drug interventions related to this trial
Analgesics
Anti-Arrhythmia Agents
Cardiovascular Agents
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
National Human Genome Research Institute (NHGRI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services